about
Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug DiscoveryThe Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic PotentialGenetic disruption of voltage-gated calcium channels in psychiatric and neurological disordersHomeostatic plasticity at the Drosophila neuromuscular junctionTrafficking mechanisms underlying neuronal voltage-gated ion channel localization at the axon initial segmentChannelopathy pathogenesis in autism spectrum disordersTowards a Unified Theory of Calmodulin Regulation (Calmodulation) of Voltage-Gated Calcium and Sodium ChannelsA Single Amino Acid Deletion (ΔF1502) in the S6 Segment of CaV2.1 Domain III Associated with Congenital Ataxia Increases Channel Activity and Promotes Ca2+ InfluxEmerging evidence for specific neuronal functions of auxiliary calcium channel α₂δ subunits.Delayed postnatal loss of P/Q-type calcium channels recapitulates the absence epilepsy, dyskinesia, and ataxia phenotypes of genomic Cacna1a mutations.Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management.The genetic relationship between epilepsy and hemiplegic migraineCalcium channels and synaptic transmission in familial hemiplegic migraine type 1 animal models.Acute Intravenous Calcium Antagonist for Suspected Hemiplegic Migraine - A Case Story.Age-related homeostatic midchannel proteolysis of neuronal L-type voltage-gated Ca²⁺ channels.The first knockin mouse model of episodic ataxia type 2New ataxic tottering-6j mouse allele containing a Cacna1a gene mutation.Functional crosstalk in culture between macrophages and trigeminal sensory neurons of a mouse genetic model of migraineG protein modulation of CaV2 voltage-gated calcium channelsStudies on the pathophysiology and genetic basis of migraine.Age-dependent contribution of P/Q- and R-type Ca2+ channels to neuromuscular transmission in lethargic mice.Regulation of voltage-gated calcium channels by proteolysis.Mechanism underlying unaltered cortical inhibitory synaptic transmission in contrast with enhanced excitatory transmission in CaV2.1 knockin migraine mice.Splice isoform-specific suppression of the Cav2.1 variant underlying spinocerebellar ataxia type 6.Abnormal excitability and episodic low-frequency oscillations in the cerebral cortex of the tottering mouse.CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channelsAdvances in imaging ultrastructure yield new insights into presynaptic biologyEslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action.Genetic Evidence for Possible Involvement of the Calcium Channel Gene CACNA1A in Autism Pathogenesis in Chinese Han Population.Large-Scale Functional RNAi Screen in C. elegans Identifies TGF-β and Notch Signaling Pathways as Modifiers of CACNA1A.Touch responsiveness in zebrafish requires voltage-gated calcium channel 2.1bConvergent mechanisms in etiologically-diverse dystoniasGenetic studies of Polish migraine patients: screening for causative mutations in four migraine-associated genesChanneling headache: novel findings in the study of Ca(2+)-channels and FHM-1Presynaptic CaV2.1 calcium channels carrying familial hemiplegic migraine mutation R192Q allow faster recovery from synaptic depression in mouse calyx of Held.Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels.Cortical spreading depression as a target for anti-migraine agents.Dominance of P/Q-type calcium channels in depolarization-induced presynaptic FM dye release in cultured hippocampal neurons.How voltage-gated calcium channels gate forms of homeostatic synaptic plasticityIon channels under the sun.
P2860
Q26744730-AF3AA786-A61C-4ABC-95FA-38B183481D41Q26781422-4BBC0D95-7E5D-4378-9A46-A05B4D2FB83FQ26783154-1AE41622-6D55-48C6-9608-8C3B20D28083Q26829672-140BD94F-7454-4611-98EC-07EE9635C727Q26829715-84A89072-4EB1-44F4-84B4-0D64A7551517Q26864726-16E31901-FA6E-449D-B532-28F5827346D9Q27002550-E674D6E1-522A-45BA-9770-9D9E539A43DBQ28118912-0F73DACE-AA16-40BE-BD49-BF5F7800471DQ30407837-CE23CF46-65BA-4E80-AAED-5D16824EDA44Q30499188-4FE4CC63-8840-4AD8-8F44-5393D42F5DA2Q31160887-807217AD-8EE9-4791-A236-F19D69A25FAAQ33621149-16B800D0-D891-4F00-9958-0D79252F52AEQ33680269-13D4AFF4-92A4-4503-9B2B-8EDE48B23769Q33706027-5BE6064B-90FA-413F-94BC-604C84DB9F03Q33736402-D6D92FA8-F35D-45F4-932B-024926B16849Q34325294-A2E653C5-CAA1-43FF-91E9-84E27F080061Q34406472-1FECB7C3-8DC5-4152-BD72-AC5989CA1152Q34484542-21AEA437-F07E-4C69-A6FA-336391BA63F9Q34639816-EC42F5CD-E94B-437F-9120-3547B0419BB8Q34658774-EA135072-6A05-4ED4-A182-672F7833CE96Q34946589-7C789221-3E9D-4B54-8A16-378CEDDE3E4FQ35166587-F5298514-E70A-4B62-90D4-D0042B4A195CQ35183351-7864AC8E-0086-42FF-958E-0268ED0A8597Q35203559-A7394CAD-B4A9-4652-BFB5-4D63C36171E7Q35307681-1190CAB5-4D0F-4B89-B0B1-631A4E6E1B8EQ35461678-DD213D23-BDF7-4440-963B-7036C84C6AD4Q35635007-6CD2D798-B1EE-4E49-8F50-A755AC2D7CB3Q35664957-927372DD-2339-4F5A-81EE-94C77CAF4BBAQ35841008-ED7D8024-769E-45FA-8B04-D1386386A64BQ35966933-68878810-C7DA-4F8B-89F6-CBDED21C8FE4Q36211246-41D8E432-65CB-4A59-AAB5-F73E3A9D0ECCQ36445234-F75136F7-F4D4-4591-8299-5F298F678266Q36446214-8AF0431C-0DEF-4564-AFE0-6A0F92787544Q36507725-5C2F951C-D318-44C2-8CDC-6E10956C0D11Q36531989-EC935B57-E705-49B0-BC53-9EBCFF97F68AQ36838951-168992E8-B72F-4BA2-AFE3-858D9B70A70CQ37056769-3DEAAA57-BCD4-4C90-BB84-01BEC569BE07Q37298042-F91FF0DE-3617-4A47-BADD-F85E9A43C17EQ37584846-539F8394-B28E-4652-8F03-0D5B40D13C8EQ37702927-82F4C033-BE65-4E62-88EF-AFBF55836AF7
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CaV2.1 channelopathies.
@ast
CaV2.1 channelopathies.
@en
CaV2.1 channelopathies.
@nl
type
label
CaV2.1 channelopathies.
@ast
CaV2.1 channelopathies.
@en
CaV2.1 channelopathies.
@nl
prefLabel
CaV2.1 channelopathies.
@ast
CaV2.1 channelopathies.
@en
CaV2.1 channelopathies.
@nl
P2860
P1433
P1476
CaV2.1 channelopathies.
@en
P2093
Daniela Pietrobon
P2860
P2888
P304
P356
10.1007/S00424-010-0802-8
P577
2010-03-04T00:00:00Z
P5875
P6179
1047118757